Price$10.84-0.85 (-7.31%)
2026-03-042026-06-05
News · 26 weeks62-94%
2025-12-142026-06-07
Mix5190d
- Insider26(51%)
- SEC Filings16(31%)
- Other6(12%)
- Earnings2(4%)
- Dividends1(2%)
Latest news
25 items- SECSEC Form 144 filed by Perrigo Company plc144 - PERRIGO Co plc (0001585364) (Subject)
- PRPerrigo to Present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce ConferenceDUBLIN, May 26, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE:PRGO), a leading global provider of consumer products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference on Tuesday, June 9th at 10:30 AM EDT. Interested parties can access the webcast on the Perrigo website at http://perrigo.investorroom.com/events-webcasts.About PerrigoPerrigo Company plc is a leading pure-play consumer health company with over a century of experience in providing hi
- INSIDERDirector Parker Geoffrey M. exercised 7,305 units of Ordinary Shares at a strike of $10.84 and covered exercise/tax liability with 3,507 units of Ordinary Shares, increasing direct ownership by 13% to 32,710 units (SEC Form 4)4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by CEO Lockwood-Taylor Patrick4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP & Chief Financial Officer Bezerra Eduardo Guarita4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP and CSO Lennox Abigail4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP and President of CSCI Khoury Roberto4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP & CBDO Ball David4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP & CHRO Willis Robert4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP, Supply, Ops, Strategy Winterman Matthew John4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP, General Counsel & Sec. Atkinson Charles4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERDirector Brown Julia M exercised 7,305 units of Ordinary Shares at a strike of $10.84 and covered exercise/tax liability with 3,507 units of Ordinary Shares, increasing direct ownership by 47% to 11,832 units (SEC Form 4)4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERDirector Manzone Albert exercised 7,305 units of Ordinary Shares at a strike of $10.84 and covered exercise/tax liability with 3,507 units of Ordinary Shares, increasing direct ownership by 30% to 16,353 units (SEC Form 4)4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERDirector Alford Bradley A exercised 7,305 units of Ordinary Shares at a strike of $10.84 and covered exercise/tax liability with 3,507 units of Ordinary Shares, increasing direct ownership by 9% to 44,958 units (SEC Form 4)4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERDirector O'Connor Donal exercised 7,305 units of Ordinary Shares at a strike of $10.84 and covered exercise/tax liability with 3,507 units of Ordinary Shares, increasing direct ownership by 12% to 34,435 units (SEC Form 4)4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERDirector Ashford Orlando D exercised 10,669 units of Ordinary Shares at a strike of $10.84 and covered exercise/tax liability with 5,122 units of Ordinary Shares, increasing direct ownership by 25% to 27,717 units (SEC Form 4)4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERDirector Egan Kevin Francis exercised 7,305 units of Ordinary Shares at a strike of $10.84 and covered exercise/tax liability with 3,507 units of Ordinary Shares (SEC Form 4)4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERDirector Samuelson Jonas exercised 7,305 units of Ordinary Shares at a strike of $10.84 and covered exercise/tax liability with 3,507 units of Ordinary Shares, increasing direct ownership by 238% to 5,392 units (SEC Form 4)4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERAmendment: Director Samuelson Jonas exercised 3,066 units of Ordinary Shares at a strike of $10.72 and covered exercise/tax liability with 1,472 units of Ordinary Shares (SEC Form 4) (for withholding tax)4/A - PERRIGO Co plc (0001585364) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Perrigo Company plcSCHEDULE 13G/A - PERRIGO Co plc (0001585364) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Perrigo Company plcSCHEDULE 13G/A - PERRIGO Co plc (0001585364) (Subject)
- PRPerrigo Reports First Quarter 2026 Financial Results From Continuing OperationsMitigating category headwinds with market share gains through implementation of Three‑S plan.Specialty Care segment achieved net sales and segment operating income growth, led by continued momentum in Compeed®, Opill®, and ellaOne® brands.Completed divestiture of Dermacosmetics business after quarter end; upfront proceeds of approximately €306 million will support debt reduction.Maintained full‑year 2026 outlook with continued expectation for second half improvement.DUBLIN, May 6, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE:PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced financial results from continuing operations for the first quart
- SECSEC Form 10-Q filed by Perrigo Company plc10-Q - PERRIGO Co plc (0001585364) (Filer)
- SECPerrigo Company plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - PERRIGO Co plc (0001585364) (Filer)
- SECSEC Form S-8 POS filed by Perrigo Company plcS-8 POS - PERRIGO Co plc (0001585364) (Filer)
PRGO FAQ
6 questionsWhat does Perrigo Company plc do?
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and...Where does PRGO stock trade?
Perrigo Company plc (PRGO) is listed on NYSE.What sector and industry is PRGO in?
Perrigo Company plc operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.What are analysts saying about PRGO?
Perrigo Company plc has had 8 recent analyst actions on file. The most recent action was from Analyst: Neutral with a $2000.00 price target on 2025-11-06. Recent price targets range from $2000.00 to $4900.00.What companies are similar to PRGO?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare PRGO side-by-side with any of them on Quantisnow.How can I track PRGO on Quantisnow?
Quantisnow aggregates Perrigo Company plc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PRGO to receive live email and push alerts on every new disclosure.